These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 14206913)
1. PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065). FERNBACH DJ Cancer Chemother Rep; 1964 Aug; 40():37-8. PubMed ID: 14206913 [No Abstract] [Full Text] [Related]
2. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA. DAVIS P Cancer Chemother Rep; 1964 Aug; 40():51-2. PubMed ID: 14206919 [No Abstract] [Full Text] [Related]
3. VINCRISTINE IN CHILDREN WITH MALIGNANT SOLID TUMORS. JAMES DH; GEORGE P J Pediatr; 1964 Apr; 64():534-41. PubMed ID: 14136871 [No Abstract] [Full Text] [Related]
4. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION. KRAKOFF IH; SAVEL H; MURPHY ML Cancer Chemother Rep; 1964 Aug; 40():53-5. PubMed ID: 14206920 [No Abstract] [Full Text] [Related]
5. HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY. GRIFFITH KM Cancer Chemother Rep; 1964 Aug; 40():33-6. PubMed ID: 14206912 [No Abstract] [Full Text] [Related]
6. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS. BLOEDOW CE Cancer Chemother Rep; 1964 Aug; 40():39-41. PubMed ID: 14206914 [No Abstract] [Full Text] [Related]
7. TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN. ORIGENES ML; BEATTY EC; BRUBAKER C; HAMMOND D; HARTMANN JR; SHORE N; WILLIAMS KO Cancer Chemother Rep; 1964 Apr; 37():41-6. PubMed ID: 14165884 [No Abstract] [Full Text] [Related]
8. ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES. GOLDIN A; VENDITTI JM; MEAD JA; GLYNN JP Cancer Chemother Rep; 1964 Aug; 40():57-74. PubMed ID: 14206921 [No Abstract] [Full Text] [Related]
9. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA. SHULLENBERGER CC Cancer Chemother Rep; 1964 Aug; 40():49-50. PubMed ID: 14206918 [No Abstract] [Full Text] [Related]
10. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS. HOWE CD; SAMUELS ML Cancer Chemother Rep; 1964 Aug; 40():47-8. PubMed ID: 14206917 [No Abstract] [Full Text] [Related]
11. [CLINICAL TESTING OF THE THERAPEUTIC EFFECT OF 1,6-BIS(2-MESYLOXYETHYLAMINO) 1,6-DIDESOXY-D-MANNITOL DI-HC1 (R 49)]. GRAF F; TAKACSI NAGY L Orv Hetil; 1964 Mar; 105():541-6. PubMed ID: 14138698 [No Abstract] [Full Text] [Related]
12. ERYTHEMA IN AREAS OF PREVIOUS IRRADIATION IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065). SEARS ME Cancer Chemother Rep; 1964 Aug; 40():31-2. PubMed ID: 14206911 [No Abstract] [Full Text] [Related]
13. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG. BICKERS JN Cancer Chemother Rep; 1964 Aug; 40():45-6. PubMed ID: 14206916 [No Abstract] [Full Text] [Related]
14. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST. SEARS ME Cancer Chemother Rep; 1964 Aug; 40():43. PubMed ID: 14206915 [No Abstract] [Full Text] [Related]
15. ELDERFIELD PYRIMIDINE MUSTARD (NSC-23436) IN ACUTE LEUKEMIA IN CHILDREN--A PHASE I STUDY. HEYN R; NEWTON W; CARTER R Cancer Chemother Rep; 1963 Dec; 33():51-5. PubMed ID: 14102083 [No Abstract] [Full Text] [Related]
16. [LEUKEMIC RETICULO-SARCOMATOSIS FOLLOWING METHYLTESTOSTERONE AND PREDNISOLONE TREATED PANMYELOPATHY AND THROMBOCYTOPENIA]. PLATTNER I Ann Paediatr; 1964; 203():SUPPL 3:1-31. PubMed ID: 14211529 [No Abstract] [Full Text] [Related]
17. PHASE I STUDIES OF PYRAZOLE (NSC-45410). FOLEY HT; SHNIDER BI; GOLD GL; UZER Y Cancer Chemother Rep; 1965 Feb; 44():45-8. PubMed ID: 14294812 [No Abstract] [Full Text] [Related]
18. CYCLOPHOSPHAMIDE (NSC-26271)-1 IN UNCOMMON MALIGNANT NEOPLASMS IN CHILDREN. HOLCOMB TM; HAGGARD ME; WINDMILLER J Cancer Chemother Rep; 1964 Mar; 36():73-5. PubMed ID: 14152279 [No Abstract] [Full Text] [Related]
19. A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS. BRUNNER KW; YOUNG CW Ann Intern Med; 1965 Jul; 63():69-86. PubMed ID: 14305970 [No Abstract] [Full Text] [Related]